Losing 21% of body weight at 8mg with manageable symptoms may be preferable to losing 24% at 12mg with persistent digestive distress
In studies of the effects of GLP-1, researchers estimate that 25 to 39 percent of the weight people lose on the drugs is muscle
MeAgain wins in a different situation: when you want shot day, food, symptoms, hydration, weight, progress, medication context, and support to live together in one trusted daily app
The cheapest path into the category is through the combination-product vector AstraZeneca is signaling - triple agonist plus amylin, plus calcitonin, plus an SGLT2 inhibitor - because that path is currently underclaimed and because the combination use-pattern generates its own defensible IP layer
"[E]xendin-4 was discovered in 1992 in the gila monster, after a researcher noticed the gilas venom caused the pancreas of bitten victims to swell." The Potential This strategy has already changed human lives